Change of interleukin-18 in OLETF rats with insulin resistance and effects of telmisartan

Wei-zhan WANG,Li-ting SUN,Zhi-qiang ZHAO,Feng-shi TIAN
2015-01-01
Abstract:Objective:To investigate change of interleukin-18 (IL-18) in OLETF rats with insulin resistance(IR), and to study the effect of angiotensin II type 1 receptor antagonists (AT1R) telmisartan on IR and the expression of IL-18, and the possible mechanisms of telmisartan improving IR. Methods:Twenty-four OLETF rats were fed with high-fat diet for 20 weeks to establish the IR model. Twenty-four OLETF rats with IR were randomly assigned into two groups:the model group (group M), in which the rats were fed with high-fat diet;the telmisartan group (group T), in which the rats were fed with high-fat diet and telmisartan[5 mg/(kg·d)]. Twelve LETO rats fed with normal diet served as normal control group (group NC). After 20 weeks of drug intervention, the weight(W),plasma levels of fasting insulin (FINS), fasting blood glucose (FBG), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and IL-18 were detected in two groups. And HOMA-IR and ISI were measured. Results:Compared with group NC, the W,FBG,TG,LDL-C and IL-18 were significantly increased in group M(P<0.05或P<0.01);compared with group M, the FBG,TG,LDL-C and IL-18 were significantly decreased in group T (P<0.05或P<0.01) . The multiple linear regression analysis showed that the serum IL-18 was an independent determinant of HOMA-IR. Conclusion:The IL-18 is an independent factor for IR, and telmisartan can improve IR by regulating blood glucose and serum lipid as well as inhibiting the expression of IL-18 .
What problem does this paper attempt to address?